Condensed Financial Information of Parent Company (Tables)
|
12 Months Ended |
Dec. 31, 2023 |
|---|
| Condensed Financial Information Disclosure [Abstract] |
|
| Schedule of Parent-only Balance Sheets |
The following table presents the parent-only balance sheets of GoodRx Holdings, Inc.: | | | | | | | | | | | | | December 31, | | (in thousands, except par values) | 2023 | | 2022 | | Assets | | | | | Cash | $ | 5 | | | $ | 5 | | | Other assets | 164 | | | — | | | Investment in subsidiary, net of distributions | 761,790 | | | 814,822 | | | Total assets | $ | 761,959 | | | $ | 814,827 | | | Liabilities and stockholders' equity | | | | | Total liabilities | $ | 1 | | | $ | — | | | Stockholders' equity | | | | Preferred stock, $0.0001 par value | — | | | — | | Common stock, $0.0001 par value | 40 | | | 40 | | | Additional paid-in capital | 2,219,321 | | | 2,263,322 | | | Accumulated deficit | (1,457,403) | | | (1,448,535) | | | Total stockholders' equity | 761,958 | | | 814,827 | | | Total liabilities and stockholders' equity | $ | 761,959 | | | $ | 814,827 | |
|
| Schedule of Parent-only Statement of Operations |
The following table presents the parent-only statements of operations of GoodRx Holdings, Inc.: | | | | | | | | | | | | | | | | | | | Year Ended December 31, | | (in thousands) | 2023 | | 2022 | | 2021 | | Equity in loss of subsidiary | $ | (8,868) | | | $ | (32,828) | | | $ | (25,254) | | | Net loss | $ | (8,868) | | | $ | (32,828) | | | $ | (25,254) | |
|
| Schedule of Parent-only Statement of Cash Flows |
The following table presents the parent-only statements of cash flows of GoodRx Holdings, Inc.: | | | | | | | | | | | | | | | | | | | Year Ended December 31, | | (in thousands) | 2023 | | 2022 | | 2021 | | Cash flows from operating activities | | | | | | | Net loss | $ | (8,868) | | | $ | (32,828) | | | $ | (25,254) | | | Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | | | | | | | Equity in loss of subsidiary | 8,868 | | | 32,828 | | | 25,254 | | | Changes in assets and liabilities: | | | | | | | Other assets | (164) | | | 80 | | | (23) | | | Other current liabilities | 1 | | | — | | | (87) | | | Net cash (used in) provided by operating activities | (163) | | | 80 | | | (110) | | | Cash flows from investing activities | | | | | | | Distribution from subsidiary | 162,287 | | | 113,117 | | | 22,777 | | | Net cash provided by investing activities | 162,287 | | | 113,117 | | | 22,777 | | | Cash flows from financing activities | | | | | | | Repurchases of Class A common stock | (103,974) | | | (101,721) | | | — | | | Proceeds from exercise of stock options | 5,941 | | | 9,159 | | | 35,021 | | | Employee taxes paid related to net share settlement of equity awards | (65,481) | | | (20,635) | | | (57,688) | | | Proceeds from employee stock purchase plan | 1,390 | | | — | | | — | | | Net cash used in financing activities | (162,124) | | | (113,197) | | | (22,667) | | | Net change in cash | — | | | — | | | — | | | Cash | | | | | | | Beginning of period | 5 | | | 5 | | | 5 | | | End of period | $ | 5 | | | $ | 5 | | | $ | 5 | |
|